kabutan

Kohjin Bio Co.,Ltd.(177A) Summary

177A
TSE Growth
Kohjin Bio Co.,Ltd.
1,510
JPY
-8
(-0.53%)
Dec 12, 3:30 pm JST
9.69
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
9.3
PBR
1.33
Yield
1.66%
Margin Trading Ratio
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
1,523 JPY 9.79 USD
Previous Close Dec 11
1,518 JPY 9.73 USD
High Dec 12, 9:08 am
1,525 JPY 9.80 USD
Low Dec 12, 12:46 pm
1,505 JPY 9.66 USD
Volume
6,900
Trading Value
0.01B JPY 0.07M USD
VWAP
1509.16 JPY 9.68 USD
Minimum Trading Value
151,000 JPY 969 USD
Market Cap
7.72B JPY 0.05B USD
Number of Trades
22
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
Mid
1-Year Average
53
1-Year High Aug 27, 2025
1,762
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 0 121,800
Nov 28, 2025 0 122,300
Nov 21, 2025 0 123,100
Nov 14, 2025 0 124,900
Nov 7, 2025 0 125,200
Company Profile
Kohjin Bio Co., Ltd. specializes in the development, manufacturing, and sales of cell culture media, as well as contract manufacturing of cell-processed products.
Sector
Chemicals
Kohjin Bio Co., Ltd. primarily focuses on the manufacturing and sales of bacterial culture media, in vitro diagnostic pharmaceuticals, and cell culture media, while also emphasizing regenerative medicine. The company particularly concentrates on developing and selling serum-free media, providing culture media for stem cells and immune cells. Additionally, they manufacture and sell antigen test kits for COVID-19 and influenza. In their cell processing business, Kohjin Bio manufactures specific cell-processed products commissioned by medical institutions and offers regulatory compliance support for regenerative medicine. Working in collaboration with domestic and international group companies, Kohjin Bio provides a wide range of products and services related to microbial testing and regenerative medicine.